Dr. Nafisah Al-Rifai
Associate Professor, Head of Pharmaceutical and Chemical Engineering
OFFICE: Building M, M-417
PHONE: +962 6 4294444 Ext. 4421
Dr. Al-Rifai graduated from the University of Jordan, Jordan, with a B. Sc. degree in chemistry in 2004 (Excellent). After that, she obtained
an M. Sc. degree in Organic Chemistry (Excellent) from the same university in 2007 under the supervision of Prof. Dr. Musa Nazer. From 2007–2010, Al-Rifai worked as a teaching and research assistant at the Pharmaceutical-chemical engineering department at the German-Jordanian University.
In 2010, she was awarded a DAAD scholarship to do her PhD in Germany. She worked under the supervision of Dr. Sabine Amslinger at the University of Regensburg, Germany. Her work involved the synthesis and biological evaluation of α-substituted chalcones. After receiving her PhD degree in 2014, Al-Rifai joined the pharmaceutical and chemical engineering department, German- Jordanian University, Jordan as an assistant professor. Her research interests are in the field of organic synthesis and Medicinal chemistry.

Educational Background

PhD in Bioorganic and Medicinal Chemistry, Regensburg University, Germany
MSc in Organic Chemistry, University of Jordan, Amman
BSc in Chemistry, University of Jordan, Amman
Research Interests

Organic synthesis and Medicinal chemistry.

Selected Publications

2023 Nafisah Al-Rifai, Anas Alshishani, Fouad Darras, Ola Taha, Shereen Abu-Jalloud, Lena Shaghlil, Yousef Al-Ebini,"Synthesis, characterization, and analytical method (UPLC-UV) validation",2023 [View]
2023 Anas J. Rasras, Rawhi H. Al-Far, Eyad A. Younes, Mohamad M. Shakdofa, Nafisah M. Al-Rifai,"Synthesis and crystal structure, Hirshfeld surface analysis, and DFT calculation of 2-((4-(1-benzyl-2-methyl-4-nitro-1H-imidazol-5-yl)piperazin-1-yl)methyl)-5-phenyl-1,3,4-oxadiazole",Journal of Molecular Structure,2023
2021 Nafisah M. Al-Rifai, Mohammad S. Mubarak,"α-Substituted Chalcones: A Key Review",ChemistrySelect (Wiley),6(46), 13224-13252,2021 [View]
2020 Ahmad Barghash, Samer I Al-Gharabli, Malak Jweihan, Maisam Tanbouz, Esra' AlBarahmieh, Eyad Hamad, Nafisah Al-Rifai, Hussam AlHawari, Lubna H Tahtamouni,"Angiotensin Converting Enzyme (ACE) Gene Polymorphism in Jordanian Type-1 and Type-2 Diabetic Patients",Jordan Journal of Biological Sciences,,13 (2),2020
2019 Ziad Abu El-Rub, Joanna Kujawa, Esra’a Albarahmiah, Nafisah Rifai, Fathieh Qaimari, Samer Al-Gharabli,"High Throughput Screening and Characterization Methods of Jordanian Oil Shale as a Case Study",Energies 2019,12(16), 3148, doi,2019 [View]
2015 Rücker, H, Al-Rifai, N, Rascle, A, Gottfried, E, Brodziak-Jarosz, L, Gerhauser, C, Dick, T, & Amslinger, S ," Enhancing the anti-inflammatory activity of chalcones by tuning the Michael acceptor site ",Organic & Biomolecular Chemistry, 3.49 Impact Factor ,2015
2015 Kaufmann KB, Al-Rifai N, Ulbrich F, Schallner N, Rücker H, Enzinger M, Petkes H, Pitzl S, Goebel U, Amslinger S," The Cytoprotective Effects of E-α-(4-Methoxyphenyl)-2',3,4,4'-Tetramethoxychalcone (E-α-p-OMe-C6H4-TMC)--A Novel and Non-Cytotoxic HO-1 Inducer",PLoS One,2015 Nov 13;10(11):e0142932. doi: 10.1371/journal.pone.0142932. PMID: 26565402; PMCID: PMC4643879.,2015
2014 Pinz, S, Unser, S, Brueggemann, S, Besl, E, Al-Rifai, N, Hermina Petkes, & Amslinger, S," The Synthetic α-Bromo-2′,3,4,4′-Tetramethoxychalcone (α-Br-TMC) Inhibits the JAK/STAT Signaling Pathway ",PLoS ONE,9(3):e90275. 3.53 Impact Factor ,2014
2013 Al-Rifai, N, Rücker, H, & Amslinger, S," Opening or Closing the Lock? When Reactivity Is the Key to Biological Activity",Chemistry - A European Journal ,19(45):15384–15395. 5.93 Impact Factor ,2013
2012 Amslinger, S, Al-Rifai, N, Winter, K, Wörmann, K, Scholz, R, Baumeister, P, & Wild, M," Reactivity assessment of chalcones by a kinetic thiol assay",Organic & Biomolecular Chemistry,3.49 Impact Factor ,2012